Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Lymphocyte Activation Gene 3 Protein market report explains the definition, types, applications, major countries, and major players of the Lymphocyte Activation Gene 3 Protein market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Merck & Co Inc
Novartis AG
Incyte Corp
Regeneron Pharmaceuticals Inc
Xencor Inc
Trellis Bioscience Inc
Symphogen A/S
Prima BioMed Ltd
GlaxoSmithKline Plc
MacroGenics Inc
Boehringer Ingelheim GmbH
Tesaro Inc
Sutro Biopharma Inc
Bristol-Myers Squibb Company
Crescendo Biologics Ltd
Enumeral Biomedical Holdings Inc
Icell Kealex Therapeutics
By Type:
BMS-986016
ENUM-006
IKT-203
IMP-701
Others
By End-User:
Chronic Inflammation
Head and Neck Cancer Squamous Cell Carcinoma
Kidney Cancer
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Lymphocyte Activation Gene 3 Protein Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Lymphocyte Activation Gene 3 Protein Outlook to 2028- Original Forecasts
-
2.2 Lymphocyte Activation Gene 3 Protein Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Lymphocyte Activation Gene 3 Protein Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Lymphocyte Activation Gene 3 Protein Market- Recent Developments
-
6.1 Lymphocyte Activation Gene 3 Protein Market News and Developments
-
6.2 Lymphocyte Activation Gene 3 Protein Market Deals Landscape
7 Lymphocyte Activation Gene 3 Protein Raw Materials and Cost Structure Analysis
-
7.1 Lymphocyte Activation Gene 3 Protein Key Raw Materials
-
7.2 Lymphocyte Activation Gene 3 Protein Price Trend of Key Raw Materials
-
7.3 Lymphocyte Activation Gene 3 Protein Key Suppliers of Raw Materials
-
7.4 Lymphocyte Activation Gene 3 Protein Market Concentration Rate of Raw Materials
-
7.5 Lymphocyte Activation Gene 3 Protein Cost Structure Analysis
-
7.5.1 Lymphocyte Activation Gene 3 Protein Raw Materials Analysis
-
7.5.2 Lymphocyte Activation Gene 3 Protein Labor Cost Analysis
-
7.5.3 Lymphocyte Activation Gene 3 Protein Manufacturing Expenses Analysis
8 Global Lymphocyte Activation Gene 3 Protein Import and Export Analysis (Top 10 Countries)
-
8.1 Global Lymphocyte Activation Gene 3 Protein Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Lymphocyte Activation Gene 3 Protein Export by Region (Top 10 Countries) (2017-2028)
9 Global Lymphocyte Activation Gene 3 Protein Market Outlook by Types and Applications to 2022
-
9.1 Global Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global BMS-986016 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global ENUM-006 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global IKT-203 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global IMP-701 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Chronic Inflammation Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Head and Neck Cancer Squamous Cell Carcinoma Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Kidney Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Lymphocyte Activation Gene 3 Protein Market Analysis and Outlook till 2022
-
10.1 Global Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.2.2 Canada Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.2.3 Mexico Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.3.2 UK Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.3.3 Spain Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.3.4 Belgium Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.3.5 France Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.3.6 Italy Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.3.7 Denmark Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.3.8 Finland Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.3.9 Norway Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.3.10 Sweden Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.3.11 Poland Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.3.12 Russia Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.3.13 Turkey Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.4.2 Japan Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.4.3 India Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.4.4 South Korea Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.4.5 Pakistan Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.4.6 Bangladesh Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.4.7 Indonesia Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.4.8 Thailand Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.4.9 Singapore Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.4.10 Malaysia Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.4.11 Philippines Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.4.12 Vietnam Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.5.2 Colombia Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.5.3 Chile Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.5.4 Argentina Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.5.5 Venezuela Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.5.6 Peru Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.5.7 Puerto Rico Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.5.8 Ecuador Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.6.2 Kuwait Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.6.3 Oman Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.6.4 Qatar Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.6.5 Saudi Arabia Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.6.6 United Arab Emirates Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.7.2 South Africa Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.7.3 Egypt Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.7.4 Algeria Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
-
10.8.2 New Zealand Lymphocyte Activation Gene 3 Protein Consumption (2017-2022)
11 Global Lymphocyte Activation Gene 3 Protein Competitive Analysis
-
11.1 Merck & Co Inc
-
11.1.1 Merck & Co Inc Company Details
-
11.1.2 Merck & Co Inc Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Merck & Co Inc Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
11.1.4 Merck & Co Inc Lymphocyte Activation Gene 3 Protein Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Novartis AG
-
11.2.1 Novartis AG Company Details
-
11.2.2 Novartis AG Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Novartis AG Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
11.2.4 Novartis AG Lymphocyte Activation Gene 3 Protein Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Incyte Corp
-
11.3.1 Incyte Corp Company Details
-
11.3.2 Incyte Corp Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Incyte Corp Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
11.3.4 Incyte Corp Lymphocyte Activation Gene 3 Protein Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Regeneron Pharmaceuticals Inc
-
11.4.1 Regeneron Pharmaceuticals Inc Company Details
-
11.4.2 Regeneron Pharmaceuticals Inc Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Regeneron Pharmaceuticals Inc Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
11.4.4 Regeneron Pharmaceuticals Inc Lymphocyte Activation Gene 3 Protein Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Xencor Inc
-
11.5.1 Xencor Inc Company Details
-
11.5.2 Xencor Inc Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Xencor Inc Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
11.5.4 Xencor Inc Lymphocyte Activation Gene 3 Protein Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Trellis Bioscience Inc
-
11.6.1 Trellis Bioscience Inc Company Details
-
11.6.2 Trellis Bioscience Inc Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Trellis Bioscience Inc Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
11.6.4 Trellis Bioscience Inc Lymphocyte Activation Gene 3 Protein Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Symphogen A/S
-
11.7.1 Symphogen A/S Company Details
-
11.7.2 Symphogen A/S Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Symphogen A/S Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
11.7.4 Symphogen A/S Lymphocyte Activation Gene 3 Protein Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Prima BioMed Ltd
-
11.8.1 Prima BioMed Ltd Company Details
-
11.8.2 Prima BioMed Ltd Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Prima BioMed Ltd Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
11.8.4 Prima BioMed Ltd Lymphocyte Activation Gene 3 Protein Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 GlaxoSmithKline Plc
-
11.9.1 GlaxoSmithKline Plc Company Details
-
11.9.2 GlaxoSmithKline Plc Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 GlaxoSmithKline Plc Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
11.9.4 GlaxoSmithKline Plc Lymphocyte Activation Gene 3 Protein Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 MacroGenics Inc
-
11.10.1 MacroGenics Inc Company Details
-
11.10.2 MacroGenics Inc Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 MacroGenics Inc Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
11.10.4 MacroGenics Inc Lymphocyte Activation Gene 3 Protein Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Boehringer Ingelheim GmbH
-
11.11.1 Boehringer Ingelheim GmbH Company Details
-
11.11.2 Boehringer Ingelheim GmbH Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Boehringer Ingelheim GmbH Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
11.11.4 Boehringer Ingelheim GmbH Lymphocyte Activation Gene 3 Protein Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Tesaro Inc
-
11.12.1 Tesaro Inc Company Details
-
11.12.2 Tesaro Inc Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Tesaro Inc Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
11.12.4 Tesaro Inc Lymphocyte Activation Gene 3 Protein Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Sutro Biopharma Inc
-
11.13.1 Sutro Biopharma Inc Company Details
-
11.13.2 Sutro Biopharma Inc Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Sutro Biopharma Inc Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
11.13.4 Sutro Biopharma Inc Lymphocyte Activation Gene 3 Protein Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Bristol-Myers Squibb Company
-
11.14.1 Bristol-Myers Squibb Company Company Details
-
11.14.2 Bristol-Myers Squibb Company Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Bristol-Myers Squibb Company Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
11.14.4 Bristol-Myers Squibb Company Lymphocyte Activation Gene 3 Protein Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Crescendo Biologics Ltd
-
11.15.1 Crescendo Biologics Ltd Company Details
-
11.15.2 Crescendo Biologics Ltd Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Crescendo Biologics Ltd Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
11.15.4 Crescendo Biologics Ltd Lymphocyte Activation Gene 3 Protein Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Enumeral Biomedical Holdings Inc
-
11.16.1 Enumeral Biomedical Holdings Inc Company Details
-
11.16.2 Enumeral Biomedical Holdings Inc Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Enumeral Biomedical Holdings Inc Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
11.16.4 Enumeral Biomedical Holdings Inc Lymphocyte Activation Gene 3 Protein Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Icell Kealex Therapeutics
-
11.17.1 Icell Kealex Therapeutics Company Details
-
11.17.2 Icell Kealex Therapeutics Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Icell Kealex Therapeutics Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
11.17.4 Icell Kealex Therapeutics Lymphocyte Activation Gene 3 Protein Product Portfolio
-
11.17.5 Recent Research and Development Strategies
12 Global Lymphocyte Activation Gene 3 Protein Market Outlook by Types and Applications to 2028
-
12.1 Global Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global BMS-986016 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global ENUM-006 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global IKT-203 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global IMP-701 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Chronic Inflammation Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Head and Neck Cancer Squamous Cell Carcinoma Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Kidney Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Lymphocyte Activation Gene 3 Protein Market Analysis and Outlook to 2028
-
13.1 Global Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.2.2 Canada Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.2.3 Mexico Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.3.2 UK Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.3.3 Spain Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.3.4 Belgium Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.3.5 France Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.3.6 Italy Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.3.7 Denmark Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.3.8 Finland Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.3.9 Norway Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.3.10 Sweden Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.3.11 Poland Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.3.12 Russia Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.3.13 Turkey Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.4.2 Japan Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.4.3 India Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.4.4 South Korea Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.4.8 Thailand Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.4.9 Singapore Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.4.11 Philippines Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.5.2 Colombia Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.5.3 Chile Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.5.4 Argentina Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.5.6 Peru Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.6.3 Oman Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.6.4 Qatar Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.7.2 South Africa Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.7.3 Egypt Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.7.4 Algeria Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Lymphocyte Activation Gene 3 Protein Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Lymphocyte Activation Gene 3 Protein
-
Figure of Lymphocyte Activation Gene 3 Protein Picture
-
Table Global Lymphocyte Activation Gene 3 Protein Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Lymphocyte Activation Gene 3 Protein Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global BMS-986016 Consumption and Growth Rate (2017-2022)
-
Figure Global ENUM-006 Consumption and Growth Rate (2017-2022)
-
Figure Global IKT-203 Consumption and Growth Rate (2017-2022)
-
Figure Global IMP-701 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Chronic Inflammation Consumption and Growth Rate (2017-2022)
-
Figure Global Head and Neck Cancer Squamous Cell Carcinoma Consumption and Growth Rate (2017-2022)
-
Figure Global Kidney Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Lymphocyte Activation Gene 3 Protein Consumption by Country (2017-2022)
-
Table North America Lymphocyte Activation Gene 3 Protein Consumption by Country (2017-2022)
-
Figure United States Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Canada Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Mexico Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Table Europe Lymphocyte Activation Gene 3 Protein Consumption by Country (2017-2022)
-
Figure Germany Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure UK Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Spain Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Belgium Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure France Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Italy Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Denmark Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Finland Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Norway Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Sweden Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Poland Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Russia Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Turkey Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Table APAC Lymphocyte Activation Gene 3 Protein Consumption by Country (2017-2022)
-
Figure China Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Japan Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure India Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure South Korea Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Thailand Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Singapore Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Philippines Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Table South America Lymphocyte Activation Gene 3 Protein Consumption by Country (2017-2022)
-
Figure Brazil Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Colombia Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Chile Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Argentina Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Peru Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Table GCC Lymphocyte Activation Gene 3 Protein Consumption by Country (2017-2022)
-
Figure Bahrain Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Oman Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Qatar Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Table Africa Lymphocyte Activation Gene 3 Protein Consumption by Country (2017-2022)
-
Figure Nigeria Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure South Africa Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Egypt Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure Algeria Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Table Oceania Lymphocyte Activation Gene 3 Protein Consumption by Country (2017-2022)
-
Figure Australia Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Lymphocyte Activation Gene 3 Protein Consumption and Growth Rate (2017-2022)
-
Table Merck & Co Inc Company Details
-
Table Merck & Co Inc Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Inc Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
Table Merck & Co Inc Lymphocyte Activation Gene 3 Protein Product Portfolio
-
Table Novartis AG Company Details
-
Table Novartis AG Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
Table Novartis AG Lymphocyte Activation Gene 3 Protein Product Portfolio
-
Table Incyte Corp Company Details
-
Table Incyte Corp Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
Table Incyte Corp Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
Table Incyte Corp Lymphocyte Activation Gene 3 Protein Product Portfolio
-
Table Regeneron Pharmaceuticals Inc Company Details
-
Table Regeneron Pharmaceuticals Inc Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
Table Regeneron Pharmaceuticals Inc Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
Table Regeneron Pharmaceuticals Inc Lymphocyte Activation Gene 3 Protein Product Portfolio
-
Table Xencor Inc Company Details
-
Table Xencor Inc Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
Table Xencor Inc Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
Table Xencor Inc Lymphocyte Activation Gene 3 Protein Product Portfolio
-
Table Trellis Bioscience Inc Company Details
-
Table Trellis Bioscience Inc Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
Table Trellis Bioscience Inc Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
Table Trellis Bioscience Inc Lymphocyte Activation Gene 3 Protein Product Portfolio
-
Table Symphogen A/S Company Details
-
Table Symphogen A/S Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
Table Symphogen A/S Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
Table Symphogen A/S Lymphocyte Activation Gene 3 Protein Product Portfolio
-
Table Prima BioMed Ltd Company Details
-
Table Prima BioMed Ltd Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
Table Prima BioMed Ltd Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
Table Prima BioMed Ltd Lymphocyte Activation Gene 3 Protein Product Portfolio
-
Table GlaxoSmithKline Plc Company Details
-
Table GlaxoSmithKline Plc Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Plc Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
Table GlaxoSmithKline Plc Lymphocyte Activation Gene 3 Protein Product Portfolio
-
Table MacroGenics Inc Company Details
-
Table MacroGenics Inc Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
Table MacroGenics Inc Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
Table MacroGenics Inc Lymphocyte Activation Gene 3 Protein Product Portfolio
-
Table Boehringer Ingelheim GmbH Company Details
-
Table Boehringer Ingelheim GmbH Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim GmbH Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
Table Boehringer Ingelheim GmbH Lymphocyte Activation Gene 3 Protein Product Portfolio
-
Table Tesaro Inc Company Details
-
Table Tesaro Inc Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tesaro Inc Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
Table Tesaro Inc Lymphocyte Activation Gene 3 Protein Product Portfolio
-
Table Sutro Biopharma Inc Company Details
-
Table Sutro Biopharma Inc Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sutro Biopharma Inc Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
Table Sutro Biopharma Inc Lymphocyte Activation Gene 3 Protein Product Portfolio
-
Table Bristol-Myers Squibb Company Company Details
-
Table Bristol-Myers Squibb Company Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
Table Bristol-Myers Squibb Company Lymphocyte Activation Gene 3 Protein Product Portfolio
-
Table Crescendo Biologics Ltd Company Details
-
Table Crescendo Biologics Ltd Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
Table Crescendo Biologics Ltd Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
Table Crescendo Biologics Ltd Lymphocyte Activation Gene 3 Protein Product Portfolio
-
Table Enumeral Biomedical Holdings Inc Company Details
-
Table Enumeral Biomedical Holdings Inc Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
Table Enumeral Biomedical Holdings Inc Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
Table Enumeral Biomedical Holdings Inc Lymphocyte Activation Gene 3 Protein Product Portfolio
-
Table Icell Kealex Therapeutics Company Details
-
Table Icell Kealex Therapeutics Lymphocyte Activation Gene 3 Protein Sales, Price, Value and Gross Profit (2017-2022)
-
Table Icell Kealex Therapeutics Lymphocyte Activation Gene 3 Protein Main Business and Markets Served
-
Table Icell Kealex Therapeutics Lymphocyte Activation Gene 3 Protein Product Portfolio
-
Figure Global BMS-986016 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ENUM-006 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global IKT-203 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global IMP-701 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chronic Inflammation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Head and Neck Cancer Squamous Cell Carcinoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kidney Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lymphocyte Activation Gene 3 Protein Consumption Forecast by Country (2022-2028)
-
Table North America Lymphocyte Activation Gene 3 Protein Consumption Forecast by Country (2022-2028)
-
Figure United States Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Lymphocyte Activation Gene 3 Protein Consumption Forecast by Country (2022-2028)
-
Figure Germany Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Lymphocyte Activation Gene 3 Protein Consumption Forecast by Country (2022-2028)
-
Figure China Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Lymphocyte Activation Gene 3 Protein Consumption Forecast by Country (2022-2028)
-
Figure Brazil Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Lymphocyte Activation Gene 3 Protein Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Lymphocyte Activation Gene 3 Protein Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Lymphocyte Activation Gene 3 Protein Consumption Forecast by Country (2022-2028)
-
Figure Australia Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Lymphocyte Activation Gene 3 Protein Consumption Forecast and Growth Rate (2022-2028)
-
